Lithium Initiation Dosing and Monitoring
For acute mania, start lithium at 600 mg three times daily (1800 mg/day total), not 300 mg daily, and check the first lithium level within one week, then twice weekly until stable. 1
Starting Dose
The FDA-approved dosing for acute mania is 600 mg three times daily, which typically produces therapeutic serum levels of 1.0-1.5 mEq/L 1. Starting at only 300 mg daily is insufficient for acute treatment and represents a maintenance dose, not an initiation dose.
However, dose individualization is critical based on patient factors:
- Elderly patients: Start lower (often 300-450 mg/day) as they are more sensitive to lithium and exhibit toxicity at levels tolerated by younger adults 1
- Younger adults (<40 years): Can typically tolerate 925-1300 mg daily for maintenance
- Middle-aged (40-60 years): Usually require 740-925 mg daily
- Older adults (>60 years): Often need only 550-740 mg daily 2
Timing of First Lithium Level
Check the first serum lithium level after one week of treatment 3, then:
- Twice weekly during the acute phase until both serum level and clinical condition stabilize 1
- Blood should be drawn 8-12 hours after the previous dose (trough level) 1
- For once-daily dosing regimens, draw at 24 hours post-dose, not 12 hours, as 12-hour levels will be falsely elevated by 1.3-fold 4
Target Therapeutic Ranges
- Acute mania: 1.0-1.5 mEq/L 1
- Maintenance therapy: 0.6-0.8 mEq/L (preferred by most current guidelines) 5, though some sources still recommend 0.8-1.2 mEq/L 1
Critical Monitoring Schedule
Baseline labs before starting lithium 6:
- Complete blood count
- Thyroid function tests (TSH, free T4)
- Renal function (BUN, creatinine, eGFR)
- Urinalysis
- Serum calcium
- Pregnancy test in females of childbearing age
Ongoing monitoring once stable 6:
- Lithium levels, renal function, thyroid function, and urinalysis every 3-6 months
- During maintenance therapy in uncomplicated cases: lithium levels at least every 2 months 1
Common Pitfalls to Avoid
- Don't rely solely on serum levels: Clinical evaluation is essential alongside laboratory values 1
- Watch for drug interactions: NSAIDs, diuretics, and ACE inhibitors reduce lithium clearance and increase toxicity risk 7
- Beware of dehydration: Increases lithium levels and toxicity risk
- Monitor for early toxicity signs: Patients sensitive to lithium may show toxicity at 1.0-1.5 mEq/L, levels normally considered therapeutic 1
- Consider once-daily dosing: Reduces renal side effects (particularly urinary frequency) compared to divided dosing, improving compliance 8